NEW DELHI: A high-level committee constituted by the Department of Pharmaceuticals (DoP) is contemplating restrictions on the exports of some crucial antibiotics and vitamins in light of the coronavirus outbreak, said people aware of the matter. This comes as traders have been raising the prices of some bulk drugs for pharmaceutical companies amid the prolonged shutdown in China.

India imports bulk drugs from China to manufacture antibiotics and then exports finished products to other c ..

Read more at:
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/panel-mulls-drug-export-curbs-to-avoid-shortage/articleshow/74053935.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst............................ET